Metabolic and bone effects of long-acting polyethylene glycol-recombinant human growth hormone in growth hormone deficiency during the transition period: a prospective study.

Ann Pediatr Endocrinol Metab · 2026 · PMC13342898 · PMID 42415557

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a favorable trendno p-value reported

During the treatment period, there was a favorable trend in treatment adherence, accompanied by a low incidence of adverse events.

also in 1,335 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.